McKinley Carter Wealth Services Inc. Has $386,000 Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

McKinley Carter Wealth Services Inc. grew its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.6% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 780 shares of the medical equipment provider’s stock after buying an additional 48 shares during the period. McKinley Carter Wealth Services Inc.’s holdings in Intuitive Surgical were worth $386,000 at the end of the most recent reporting period.

A number of other institutional investors have also made changes to their positions in the stock. Onefund LLC grew its stake in shares of Intuitive Surgical by 1.9% during the fourth quarter. Onefund LLC now owns 947 shares of the medical equipment provider’s stock worth $494,000 after purchasing an additional 18 shares during the period. AlphaCore Capital LLC grew its stake in shares of Intuitive Surgical by 4.2% during the fourth quarter. AlphaCore Capital LLC now owns 451 shares of the medical equipment provider’s stock worth $235,000 after purchasing an additional 18 shares during the period. Parkside Financial Bank & Trust grew its stake in shares of Intuitive Surgical by 2.6% during the fourth quarter. Parkside Financial Bank & Trust now owns 747 shares of the medical equipment provider’s stock worth $390,000 after purchasing an additional 19 shares during the period. Accredited Investors Inc. grew its stake in shares of Intuitive Surgical by 1.9% during the fourth quarter. Accredited Investors Inc. now owns 1,040 shares of the medical equipment provider’s stock worth $543,000 after purchasing an additional 19 shares during the period. Finally, Second Line Capital LLC grew its stake in shares of Intuitive Surgical by 3.4% during the fourth quarter. Second Line Capital LLC now owns 578 shares of the medical equipment provider’s stock worth $302,000 after purchasing an additional 19 shares during the period. 83.64% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities research analysts recently commented on the company. Royal Bank of Canada decreased their price objective on Intuitive Surgical from $630.00 to $605.00 and set an “outperform” rating for the company in a research note on Wednesday, April 23rd. Truist Financial decreased their target price on Intuitive Surgical from $605.00 to $590.00 and set a “buy” rating for the company in a research note on Wednesday, April 23rd. Barclays decreased their target price on Intuitive Surgical from $684.00 to $635.00 and set an “overweight” rating for the company in a research note on Thursday, April 24th. Piper Sandler decreased their target price on Intuitive Surgical from $670.00 to $575.00 and set an “overweight” rating for the company in a research note on Wednesday, April 23rd. Finally, Deutsche Bank Aktiengesellschaft cut Intuitive Surgical from a “hold” rating to a “sell” rating and decreased their target price for the company from $515.00 to $440.00 in a research note on Monday. One research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have issued a buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $588.95.

Intuitive Surgical Stock Performance

ISRG opened at $522.41 on Thursday. Intuitive Surgical, Inc. has a 52-week low of $413.82 and a 52-week high of $616.00. The firm has a market capitalization of $187.24 billion, a PE ratio of 81.50, a PEG ratio of 5.85 and a beta of 1.67. The business’s 50-day simple moving average is $524.49 and its 200 day simple moving average is $538.83.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The business had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. During the same quarter in the prior year, the company posted $1.50 earnings per share. On average, research analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, EVP Gary Loeb sold 1,700 shares of the company’s stock in a transaction that occurred on Friday, April 25th. The stock was sold at an average price of $513.18, for a total value of $872,406.00. Following the sale, the executive vice president now owns 2,245 shares in the company, valued at $1,152,089.10. This represents a 43.09% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Jami K. Nachtsheim sold 2,400 shares of the company’s stock in a transaction that occurred on Thursday, May 1st. The shares were sold at an average price of $520.00, for a total value of $1,248,000.00. Following the completion of the sale, the director now owns 6,371 shares in the company, valued at $3,312,920. This represents a 27.36% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 4,998 shares of company stock worth $2,611,577 over the last 90 days. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.